Table 1

Personal characteristics of participants according to age and severity of hemophilia

SevereModerateMild
Born before introduction prophylaxis (31–64 y), no200 77 260 
    Type of hemophilia    
        Hemophilia A 170 (85) 71 (92) 226 (87) 
        Hemophilia B 30 (15) 6 (8) 34 (13) 
    Treatment modalities    
        Prophylactic 105 (53) 7 (9) 1 (0.4) 
        On demand 28 (14) 53 (71) 218 (91) 
    Viral infections    
        Hepatitis C 149 (75) 42 (64) 66 (43) 
        HIV 17 (9) 3 (5) 3 (2) 
Born after introduction prophylaxis (16–30 y), no79 37 68 
    Type of hemophilia    
        Hemophilia A 65 (82) 32 (86) 59 (87) 
        Hemophilia B 14 (16) 5 (14) 9 (13) 
    Treatment modalities    
        Prophylactic 64 (81) 7 (19) 1 (2) 
        On demand 8 (10) 22 (59) 52 (76) 
    Viral infections    
        Hepatitis C positive 39 (49) 11 (30) 7 (10) 
        HIV positive 6 (8) 
SevereModerateMild
Born before introduction prophylaxis (31–64 y), no200 77 260 
    Type of hemophilia    
        Hemophilia A 170 (85) 71 (92) 226 (87) 
        Hemophilia B 30 (15) 6 (8) 34 (13) 
    Treatment modalities    
        Prophylactic 105 (53) 7 (9) 1 (0.4) 
        On demand 28 (14) 53 (71) 218 (91) 
    Viral infections    
        Hepatitis C 149 (75) 42 (64) 66 (43) 
        HIV 17 (9) 3 (5) 3 (2) 
Born after introduction prophylaxis (16–30 y), no79 37 68 
    Type of hemophilia    
        Hemophilia A 65 (82) 32 (86) 59 (87) 
        Hemophilia B 14 (16) 5 (14) 9 (13) 
    Treatment modalities    
        Prophylactic 64 (81) 7 (19) 1 (2) 
        On demand 8 (10) 22 (59) 52 (76) 
    Viral infections    
        Hepatitis C positive 39 (49) 11 (30) 7 (10) 
        HIV positive 6 (8) 

Data are numbers (%).

Close Modal

or Create an Account

Close Modal
Close Modal